Effects of prolonged-release melatonin and zolpidem on postural stability in older adults

Human Psychopharmacology
S OtmaniAmnon Katz

Abstract

A prolonged-release formulation of melatonin (PR-M) is indicated for insomnia in patients aged 55 years and older. Because hypnotics result in impairments of body sway, it was important to evaluate the effect of 2 mg PR-M on postural stability in older adults at night. Twenty-four healthy volunteers (12 women, 12 men, aged 55-64 years) completed a randomized, double-blind, single-dose, three-way crossover study of postural stability of PR-M 2 mg, zolpidem 10 mg (active control) or placebo. Subjects were tested for body sway 30 min before, 1.5 and 4 h after dosing. Parameters tested were the area of the 95% confidence ellipse enclosing the center of pressure (COP; [A95]) and COP path length. Zolpidem significantly increased the A95 (both eyes conditions at all time points) and path length of COP. PR-M had no effect on A95 (both "eyes closed" and "eyes open" conditions at all time points) compared with placebo and increased COP path length by 10% at 4 h post-dose in open but not closed eyes condition. No serious adverse events were observed. In older adults, evening PR-M intake did not impair postural stability during the night. The postural instability with zolpidem demonstrated assay sensitivity and validated the outcome.

References

Nov 1, 1989·Neurobiology of Aging·F B HorakA Mirka
Aug 1, 1994·Journal of Clinical Epidemiology·H LuukinenS L Kivelä
Mar 1, 1996·Trends in Pharmacological Sciences·S M ReppertC Godson
May 20, 1998·Pharmacology, Biochemistry, and Behavior·M J MattilaT Seppälä
Oct 17, 1998·Journal of Travel Medicine·A SuhnerR Steffen
Jan 27, 1999·Journal of the American Geriatrics Society·R M LeipzigM E Tinetti
Jun 16, 2000·Journal of the American Geriatrics Society·W A RayP Gideon
Jan 5, 2002·Age and Ageing·T Masud, R O Morris
Feb 15, 2002·Journal of the American Geriatrics Society·P S WangJ Avorn
Aug 16, 2002·Clinics in Geriatric Medicine·Laurence Z Rubenstein, Karen R Josephson
Aug 20, 2002·Postgraduate Medical Journal·C FrelsS E Gariballa
Oct 9, 2002·Journal of the American Geriatrics Society·Kristine E EnsrudUNKNOWN Study of Osteoporotic Fractures Research Group
Aug 19, 2003·CNS Drugs·Robert G Cumming, David G Le Couteur
Nov 15, 2005·BMJ : British Medical Journal·Jennifer GlassUsoa E Busto
Jan 24, 2006·NeuroImage·Tali GorfineNava Zisapel
Jan 27, 2007·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Bahi TakkoucheMahyar Etminan
Sep 4, 2007·Brain Research Reviews·Kaoru Takakusaki
Nov 23, 2007·Sleep Medicine·Margarita L Dubocovich
Oct 22, 2008·Archives of Physical Medicine and Rehabilitation·Christoph BauerKarl Günter Gassmann
Jul 9, 2009·International Clinical Psychopharmacology·Remy LuthringerLuc Staner
Aug 13, 2010·Current Opinion in Supportive and Palliative Care
Nov 26, 2010·Sleep Medicine·Maurice M Ohayon, Teresa Sagales
Mar 16, 2011·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Nancye May Peel

❮ Previous
Next ❯

Citations

Jun 5, 2012·European Journal of Clinical Pharmacology·Antonio RuggieroRiccardo Riccardi
Oct 10, 2012·Drugs & Aging·Katherine A Lyseng-Williamson
Oct 4, 2014·Zeitschrift für Gerontologie und Geriatrie·J SchlitzerH Frohnhofen
Jul 16, 2013·Maturitas·Marcello MaggioGian Paolo Ceda
Oct 7, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Daniel P CardinaliDaniel E Vigo
Aug 9, 2016·Age and Ageing·Martin FrisherScott Weich
Aug 31, 2018·Journal of Aging and Physical Activity·Anis KamounMohamed Habib Elleuch
May 29, 2018·Journal of Aging and Physical Activity·Ming Fung Godfrey LuiWai Nam William Tsang
May 2, 2018·Journal of Alzheimer's Disease : JAD·Paola ProserpioLino Nobili
Sep 4, 2020·Climacteric : the Journal of the International Menopause Society·P ProserpioR E Nappi
Aug 22, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Arezoo Fathalizadeh AlamdariSarvin Sanaie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.